Education
About Us
Working with TipRanks
Follow Us
HEAL - ETF AI Analysis
Top Page
Global X HealthTech ETF (HEAL)
Rating:61Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several top holdings, such as Tempus AI and Hims & Hers Health, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Health Care Focus
The ETF’s heavy exposure to the health care sector provides access to a growing industry with long-term potential.
Steady Performance
The ETF has shown consistent positive returns across year-to-date, three-month, and one-month periods, indicating solid momentum.
Negative Factors
High Sector Concentration
Nearly 88% of the ETF is allocated to health care, which limits diversification and increases sector-specific risk.
Geographic Overweight in USA
Over 83% of the fund’s exposure is in U.S. companies, reducing protection against risks in the domestic market.
Moderate Expense Ratio
The ETF’s expense ratio of 0.5% is higher than some low-cost alternatives, which could eat into long-term returns.
HEAL vs. SPDR S&P 500 ETF (SPY)
AUM51.05M
RegionGlobal
Expense Ratio0.50%
Beta1.02
IssuerGlobal X
Inception DateJul 29, 2020
Dividend Yield0.08%
Asset ClassEquity
Index TrackedGlobal X HealthTech Index - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,165
30 Day Avg. Volume5,506
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
38.83Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering40
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HEAL Summary
The Global X HealthTech ETF (ticker: HEAL) focuses on companies driving innovation in healthcare through technology, such as telemedicine, digital health platforms, and remote patient monitoring. It includes well-known names like IQVIA Holdings and Veeva Systems, along with other leaders in the health tech space. This ETF is ideal for investors looking to benefit from the growing demand for accessible, tech-driven healthcare solutions, especially as digital transformation accelerates globally. However, new investors should note that its performance is closely tied to the health tech sector, which can be volatile and influenced by changes in technology trends or healthcare regulations.
How much will it cost me?The Global X HealthTech ETF (HEAL) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on a specialized sector like health technology, which requires more research and expertise.
What would affect this ETF?The Global X HealthTech ETF (EDOC) could benefit from increasing demand for telemedicine and digital health solutions as healthcare systems worldwide continue to embrace technology for efficiency and accessibility. However, potential risks include regulatory changes in healthcare technology or slower adoption rates in certain regions, which could impact the growth of companies in its portfolio. Additionally, economic downturns or rising interest rates might negatively affect the performance of smaller, innovative firms within the ETF.
HEAL Top 10 Holdings
The Global X HealthTech ETF is heavily concentrated in healthcare innovation, with names like Dexcom and GE Healthcare Technologies shaping its performance. Dexcom has been lagging recently, weighed down by bearish momentum and operational challenges, while GE Healthcare is steady but uninspiring, facing cash flow pressures. On the brighter side, TransMedics Group and Intuitive Surgical are rising stars, benefiting from strong financial growth and strategic advancements. The fund’s global exposure adds diversity, but its focus on digital health and telemedicine means it’s riding the wave of healthcare’s tech-driven transformation.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TransMedics Group | 4.71% | $2.40M | $4.84B | 96.33% | 77 Outperform | |
| Dexcom | 4.42% | $2.26M | $25.14B | -20.34% | 77 Outperform | |
| GE Healthcare Technologies Inc | 4.20% | $2.14M | $36.54B | -3.36% | 74 Outperform | |
| IQVIA Holdings | 4.19% | $2.14M | $38.42B | 12.49% | 77 Outperform | |
| Tempus AI, Inc. Class A | 4.17% | $2.13M | $13.16B | 31.41% | 49 Neutral | |
| Irhythm Technologies | 4.13% | $2.11M | $5.86B | 111.44% | 58 Neutral | |
| Pro Medicus Limited | 4.10% | $2.09M | AU$27.16B | 4.77% | 69 Neutral | |
| Intuitive Surgical | 3.92% | $2.00M | $201.25B | 3.23% | 78 Outperform | |
| Insulet | 3.92% | $2.00M | $21.74B | 14.59% | 74 Outperform | |
| Waystar Holding Corp. | 3.91% | $1.99M | $6.69B | 17.47% | 72 Outperform |
HEAL Technical Analysis
Positive
―
Price Trends
31.64
Negative
31.59
Negative
31.03
Positive
Market Momentum
-0.09
Negative
51.33
Neutral
72.90
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HEAL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.57, equal to the 50-day MA of 31.64, and equal to the 200-day MA of 31.03, indicating a neutral trend. The MACD of -0.09 indicates Negative momentum. The RSI at 51.33 is Neutral, neither overbought nor oversold. The STOCH value of 72.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HEAL.
HEAL Peer Comparison
Comparison Results
Performance Comparison
HEAL
Global X HealthTech ETF
31.21
-0.24
-0.76%
FMED
Fidelity Disruptive Medicine ETF
―
―
―
MEDI
Harbor Health Care ETF
―
―
―
MEDX
Horizon Kinetics Medical ETF
―
―
―
TMED
T. Rowe Price Health Care ETF
―
―
―
JDOC
JPMorgan Healthcare Leaders ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents